Christopher Wright
Direttore/Membro del Consiglio presso ALKERMES PLC
Patrimonio netto: 347 426 $ in data 30/06/2024
Posizioni attive di Christopher Wright
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALKERMES PLC | Direttore/Membro del Consiglio | 24/05/2022 | - |
| Independent Dir/Board Member | 24/05/2022 | - | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Christopher Wright
Precedenti posizioni note di Christopher Wright
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - | 26/03/2021 |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Direttore Tecnico/Scientifico/R&S | - | - |
| Harvard Medical School | Corporate Officer/Principal | - | - |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2017 | - |
| AXCA HEALPAR | Direttore Tecnico/Scientifico/R&S | - | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - | - |
Formazione di Christopher Wright
| Harvard University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
| Vrije Universiteit Amsterdam | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 9 |
| Regno Unito | 2 |
| Irlanda | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Settori
| Health Technology | 8 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| AXCA HEALPAR | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| ALKERMES PLC | Health Technology |
| Aziende private | 2 |
|---|---|
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Christopher Wright
- Esperienza
